Azetukalner Psychiatry Enrollment Pause
Xenon voluntarily paused enrollment of new participants in its Phase III major-depressive-disorder and bipolar-depression studies after reviewing neuropsychiatric adverse events. Existing randomized and open-label-extension participants remain on study, and the company expects the pause…
